Blood Test Might Predict Worsening of MS

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 13, 2023.

By Ernie Mundell HealthDay Reporter

KEY TAKEAWAYS:

  • The progression of multiple sclerosis is particularly difficult to predict, varying widely between patients

  • A new blood test uses a biomarker of nerve cell damage to accurately predict progression over the next two years

  • If the test proves valid, it might help patients and their doctor plan optimal treatments, the researchers said

  • MONDAY, Nov. 13, 2023 -- One issue hampering the care of people with multiple sclerosis is assessing just how quickly the neurological illness might progress.

    Now, a team at the University of California, San Francisco (UCSF), say they've spotted at test that could help do just that.

    Blood tests showing elevated levels of Nfl, a "biomarker" indicating nerve damage, seemed to predict with high accuracy a worsening of MS symptoms over the next two years, the researchers found.

    That could help patients and their physicians with treatment planning, said a team led by Dr. Ahmed Abdelhak, of the UCSF Department of Neurology and the Weill Institute for Neurosciences.

    “This rising of NfL up to two years before signs of disability worsening represents the window when interventions may prevent worsening,” Abdelhak explained in a UCSF news release.

    An MS patient's level of disability is typically measured by what's known as the Expanded Disability Status Scale. In the study, Abdelhak's group used the scale to track how quickly symptoms progressed among individuals in a cohort of almost 1,900 patients with MS. Patients were tracked for about 10 years.

    The findings highlighted the unpredictability of MS progression. Among the cohort, 570 patients showed a steady worsening of symptoms, while the disease remained relatively stable over the 10-year period.

    Blood tests targeting Nfl seemed to predict whose disease would or wouldn't progress.

    "Elevated NfL levels were associated with up to a 91% higher risk of worsening disability, with relapse approximately a year later, and up to a 49% higher risk of worsening disability without relapse nearly two years later," the researchers said.

    The study was published Nov. 6 in the journal JAMA Neurology.

    The study "aligns with recognition that death of nerve cells is a slow process that builds toward permanent disability and means that interventions to protect nerve cells might have time to also stop disability," said study co-senior author Dr. Ari Green, medical director of the UCSF Multiple Sclerosis and Neuroinflammation Center.

    Sources

  • UCSF news release, Nov. 6, 2023
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords